Configure, sample and produce your supplement range in one place.
At a glance
- Format suitability
- Reviewed for gummies — confirmed per project.
Why brands use it
Why brands use Lemon Balm
Lemon Balm is a botanical extract reviewed against the target market’s botanical rules, sitting in the botanicals family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only EU 432/2012- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Lemon Balm for gummies; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — we don’t publish off-the-shelf doses.
FormulationHow we use Lemon Balm in formulas
A public-safe formulation reference — how this active behaves in our
formats, common pairings and handling notes. Final formulation, dose and
on-pack copy are confirmed per project.
- Heat stable
- Limited — use coated forms
- Soluble in matrix
- Conditional
- Vegan supply
- Project-specific
Claim wordingEU-authorised health claims
EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.
Botanical actives like Lemon Balm sit in a partially-harmonised EU claims position: most botanical health claims remain on hold (the "on-hold list"), and country-level rules (Italy, France, Spain, Belgium) layer on top with their own positive and negative lists for botanical use. Novel-food status is checked before any brief moves forward, alongside any traditional-use route where it applies. UK rules track EU wording post-Brexit but the GB market follows its own retained list. For the US market, structure-function wording under DSHEA applies, with the FDA disclosure on pack. Pack copy is rewritten per market and reviewed per project.
EU-authorised health claims Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.
Serving
Typical serving and reference level
Where the serving level for Lemon Balm is set, and who sets it. The
figure that reaches your label is fixed against the specification for your
formula and your market — not read off this page.
- Measured in
- mg
Reference level Typical anchor: mg per serving — confirmed per project.
Lemon Balm is measured by weight (mg) per serving on DAT Supply briefs. The working anchor — the inclusion rate against which target-market claim wording is reviewed — is set during the formulation pass for each project rather than published as a fixed number on the public page. Final per-serving load depends on the chosen format (gummy payload window, capsule fill weight, softgel oil load, sachet or powder scoop size, oral-liquid bottle geometry) and the claim wording the brand needs to support against the target market. Sourcing form (extract ratio, standardised marker, micronised vs granular, salt or chelate form) is reviewed in the same pass. Country-level upper limits (France, Italy, Belgium for the EU; California Prop 65 for the US) are checked before any inclusion rate is finalised. Dose is confirmed per project — we don’t publish off-the-shelf dose tables for any active in the catalogue.
Research library
The evidence behind Lemon Balm
3 studies relevant to Lemon Balm, strongest
evidence first. Peer-reviewed sources and regulatory opinions. Citations only — DAT cites
the science, it does not endorse the publishers. Studies are on the ingredient, not on any
finished product.
Lemon BalmPeer-reviewed studyModerate evidence
Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm)
- Population
- 18 healthy volunteers
- Studied dose
- 300 mg and 600 mg
- Duration
- single dose
Single dose of 300 mg and 600 mg lemon balm extract reduced subjective stress and improved mood in a laboratory stress test.
Lemon BalmPeer-reviewed studyModerate evidence
Effects of lemon balm (Melissa officinalis) on sleep: a systematic review
- Population
- Various (insomnia patients, healthy adults)
- Studied dose
- 300-1200 mg/day
- Duration
- 2-4 weeks
Systematic review of 5 RCTs found lemon balm improved sleep quality, especially when combined with other herbs.
Lemon BalmPeer-reviewed studyModerate evidence
Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial
- Population
- 42 patients with mild to moderate Alzheimer's
- Studied dose
- 60 drops/day (standardized extract)
- Duration
- 4 months
Lemon balm extract (60 drops/day) improved cognitive function and reduced agitation in Alzheimer's patients over 4 months.
The formulas above sit in these private-label ranges:
Adjacent actives
Ingredients that sit alongside this one
Start Build a formula around Lemon Balm
Explore the private-label options that use Lemon Balm — review formula, format and packaging on each product before you commit.
